Safety of mRNA COVID-19 vaccinations in patients with allergic diseases

OBJECTIVES: The aim of this study was to determine the degree of safety and possible risk of acute allergic reactions following mRNA COVID-19 vaccination among a group of patients predisposed to allergic diseases. STUDY DESIGN: The study survey took place between May 2021 and February 2022. Each par...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosada, Tomasz, Napiórkowska – Baran, Katarzyna, Cała, Łukasz, Alska, Ewa, Paulina, Kęsicka, Czarnowska, Marta, Bartuzi, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789542/
https://www.ncbi.nlm.nih.gov/pubmed/36590876
http://dx.doi.org/10.1016/j.puhip.2022.100354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789542/
https://www.ncbi.nlm.nih.gov/pubmed/36590876
http://dx.doi.org/10.1016/j.puhip.2022.100354

Ejemplares similares